The presence of hypoxia-response elements (HRE) within the PD-L1 promoter region has highlighted a therapeutically attractive link between hypoxia/angiogenesis and anti-tumor immune suppression,26 with similar mechanisms being implied in the regulation of PD-L2 expression.27 Here, PDCD1LG2 is linked to neoplasm.